Aurinia Pharmaceuticals Inc (AUPH)

EBITDA

$54.57M

Quarterly · Period ending: · USD

AUPH logo

AUPH EBITDA

Latest reported$54.57M
AUPH Quarterly EBITDA (-$132.58K → $54.57M)
High-resolution chart · PNG

AUPH ebitda history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Aurinia Pharmaceuticals Inc EBITDA — Quarterly (USD)
Period endingEBITDA (USD)
54,568,000
49,753,000
47,068,000
36,827,000
28,137,000
30,272,000
7,181,000
20,908,000
7,519,000
-3,880,000
-20,157,000
-6,487,000
-11,350,000
-25,053,000
-24,972,000
-7,226,000
-34,666,000
-36,782,000
-31,908,000
-49,481,000
-46,144,000
-50,127,000
-9,558,000
-41,971,000
-26,370,000
-24,846,000
-75,990,000
-18,614,000
-15,490,000
-12,021,000
-14,308,000
-17,934,000
-15,304,000
-15,079,000
-12,298,000
-13,428,000
-9,679,000
-10,203,000
-7,660,000
-5,028,000
-4,187,000
-4,460,000
-8,547,000
-5,994,000
-5,689,000
-5,178,000
-4,509,000
-3,777,000
-4,177,000
-3,344,000
-789,373
-3,016,000
-848,000
-679,000
-4,981,023
-1,473,203
-1,698,948
-239,549
2,427,346
-876,939
5,128,260
-1,550,555
-2,251,833
-1,158,827
-210,606
-691,583
-1,383,462
-1,594,224
-2,285,859
-2,486,735
-898,393
-3,457,397
-5,219,188
-4,842,126
-8,564,181
-7,777,919
-9,399,718
-6,700,763
-5,807,359
-6,199,176
-5,808,652
-4,517,070
-8,911,703
-6,462,541
-6,580,193
-6,937,257
-7,971,147
-6,204,900
-3,293,677
-3,026,189
-4,794,906
-3,821,265
2,072,072
-2,986,824
-2,791,961
1,851,863
2,472,321
-2,269,108
-2,310,815
-3,182,422
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.